Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Satoshi Sakamoto has a total of 151 co-authors. Here are the top co-authors by number of shared publications:

  • Hiroshi Handa

    Department of Chemical Biology, Tokyo Medical University 4 , Tokyo 160-0023, Japan

    9 shared publications
  • Hiroshi Handa

    Department of Molecular Pharmacology, Center for Future Medical Research, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan

    8 shared publications
  • Mamoru Hatakeyama

    FG Beads Development Section, Biotronics Laboratory, Tamagawa Seiki Co. Ltd, Nagano, Japan

    5 shared publications
  • Yuki Yamaguchi

    School of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Japan

    5 shared publications
  • Akihiro Kuwahata

    Graduate School of Engineering, Tohoku University, Sendai, Japan

    4 shared publications
  • Miki Kaneko

    Department of Electrical Engineering and Information Systems, Graduate School of Engineering, the University of Tokyo 1 , Tokyo 113-8656, Japan

    4 shared publications

Latest Publications

  • Open Access

    Application of Magnetic Nanoparticles for Rapid Detection and In Situ Diagnosis in Clinical Oncology

    by Tatsuya Onishi, Kisyo Mihara, Sachiko Matsuda, Satoshi Sakamoto, Akihiro Kuwahata, Masaki Sekino, Moriaki Kusakabe, Hiroshi Handa, Yuko Kitagawa

    Screening, monitoring, and diagnosis are critical in oncology treatment. However, there are limitations with the current clinical methods, notably the time, cost, and special facilities required for radioisotope-based methods. An alternative approach, which uses magnetic beads, offers faster analyses with safer materials over a wide range of oncological applications. Magnetic beads have been used to detect extracellular vesicles (EVs) in the serum of pancreatic cancer patients with statistically different EV levels in preoperative, postoperative, and negative control samples. By incorporating fluorescence, magnetic beads have been used to quantitatively measure prostate-specific antigen (PSA), a prostate cancer biomarker, which is sensitive enough even at levels found in healthy patients. Immunostaining has also been incorporated with magnetic beads and compared with conventional immunohistochemical methods to detect lesions; the results suggest that immunostained magnetic beads could be used for pathological diagnosis during surgery. Furthermore, magnetic nanoparticles, such as superparamagnetic iron oxide nanoparticles (SPIONs), can detect sentinel lymph nodes in breast cancer in a clinical setting, as well as those in gallbladder cancer in animal models, in a surgery-applicable timeframe. Ultimately, recent research into the applications of magnetic beads in oncology suggests that the screening, monitoring, and diagnosis of cancers could be improved and made more accessible through the adoption of this technology.


  • UGGT1 retains proinsulin in the endoplasmic reticulum in an arginine dependent manner

    by Jaeyong Cho, Masaki Hiramoto, Yuka Masaike, Satoshi Sakamoto, Yoichi Imai, Yumi Imai, Hiroshi Handa, Takeshi Imai


  • Open Access

    Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide

    by Shumpei Tateno, Midori Iida, Satoshi Fujii, Tetsufumi Suwa, Miki Katayama, Haruka Tokuyama, Junichi Yamamoto, Takumi Ito, Satoshi Sakamoto, Hiroshi Handa, et al.

    Pomalidomide, a derivative of thalidomide, is an effective treatment for multiple myeloma. The drug exerts its effects through CRBN, a component of the E3 ubiquitin ligase complex CRL4CRBN. To search for novel factors involved in the anti-cancer activity of pomalidomide, we performed a genome-wide shRNA library screen and identified 445 genes as those affecting pomalidomide sensitivity. Genes encoding components of the ubiquitin-proteasome pathway, such as subunits of the CRL4CRBN complex, the COP9 signalosome, and the 26S proteasome, were among the pomalidomide-affecting genes. Karyopherin beta 1 (KPNB1) was identified as a novel pomalidomide-affecting gene. KPNB1 was required for the nuclear import of CRBN and for the CRBN-directed, pomalidomide-dependent degradation of a clinically relevant substrate, the transcription factor Aiolos. By contrast, the cytoplasmic translation factor GSPT1 was degraded following treatment with the thalidomide derivative CC-885 only when CRBN was present in the cytoplasm, indicating that subcellular distribution of CRBN is critical for the efficacy of thalidomide-based medications.


  • Open Access

    Development of an optimized dome-shaped magnet for rapid magnetic immunostaining

    by Masaki Sekino, Akihiro Kuwahata, Shunsuke Fujita, Sachiko Matsuda, Miki Kaneko, Shinichi Chikaki, Satoshi Sakamoto, Itsuro Saito, Hiroshi Handa, Moriaki Kusakabe

    Magnetic immunostaining is a technique used to accelerate the antigen-antibody immunoreaction by increasing the local density of antibody on the surface of a tissue specimen using a magnetic field. The high density of antibody is achieved by applying a magnetic force to antibody-labeled ferrite beads toward the specimen. A technical challenge of using conventional magnets for this technique has been the inhomogeneous accumulation of magnetic beads on the specimen in accordance with the distribution of the magnetic field. Thus, in this study, a dome-shaped magnet that generated a strong and uniform magnetic force distribution was proposed and demonstrated. Numerical analysis was used to optimize the shape of the magnet. Analysis of the motion of magnetic beads showed that the accumulation of beads on the sample was complete within one minute and that the resulting homogeneity was sufficient for rapid and accurate immunostaining. Finally, experiments showed that the homogeneity of the bead distribution was improved by the use of a prototype dome-shaped magnet compared to conventional cylindrical magnets.


  • Open Access

    Development of an automatic magnetic immunostaining system for rapid intraoperative diagnosis of cancer metastasis

    by Masaki Sekino, Akihiro Kuwahata, Akinobu Yoshibe, Kiyotaka Imai, Miki Kaneko, Shinichi Chikaki, Itsuro Saito, Akinori Tsuruma, Satoshi Sakamoto, Hiroshi Handa, et al.

    Magnetic immunostaining provides a novel technique for rapid intraoperative diagnosis of cancer metastasis and its characteristics in lymph nodes. Previous studies have shown the effectiveness of this technique using the manual staining process. However, to make this technique feasible for use in hospitals, establishing an automatic process is important. Thus, the objective of this study is to realize a device for immunostaining using magnetic fields that could not only automatically stain the samples, but also wash the specimen and change experimental solutions as well. The specifications for our prototype device were determined based on the manually performed experiments. We successfully fabricated a prototype device and demonstrated automatic immunostaining using it. The device completed, within 10 minutes, processes of blocking the specimen, injection of the magnetic beads, antigen-antibody reaction, and washing out the beads. The reaction took 1 minute, which was significantly shorter than that of conventional immunostaining. The device is expected to provide improved reproducibility of staining because of its automated processes.


  • Open Access

    Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation

    by Hideki Ando, Tomomi Sato, Takumi Ito, Junichi Yamamoto, Satoshi Sakamoto, Nobuhiro Nitta, Tomoko Asatsuma-Okumura, Nobuyuki Shimizu, Ryota Mizushima, Ichio Aoki, et al.


  • Open Access

    Magnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue Sections

    by Tatsuya Onishi, Sachiko Matsuda, Yuki Nakamura, Junko Kuramoto, Akinori Tsuruma, Satoshi Sakamoto, Shunichi Suzuki, Daiichiro Fuchimoto, Akira Onishi, Shinichi Chikaki, et al.

    Current immunohistochemistry methods for diagnosing abnormal cells, such as cancer cells, require multiple steps and can be relatively slow compared with intraoperative frozen hematoxylin and eosin staining, and are therefore rarely used for intraoperative examination. Thus, there is a need for novel rapid detection methods. We previously demonstrated that functionalized fluorescent ferrite beads (FF beads) magnetically promoted rapid immunoreactions. The aim of this study was to improve the magnetically promoted rapid immunoreaction method using antibody-coated FF beads and a magnet subjected to a magnetic field. Using frozen sections of xenograft samples of A431 human epidermoid cancer cells that express high levels of epidermal growth factor receptor (EGFR) and anti-EGFR antibody-coated FF beads, we reduced the magnetically promoted immunohistochemistry procedure to a 1-min reaction and 1-min wash. We also determined the optimum magnetic force for the antibody reaction (from 7.79 × 10−15 N to 3.35 × 10−15 N) and washing (4.78 × 10−16 N), which are important steps in this technique. Furthermore, we stained paraffin-embedded tissue arrays and frozen sections of metastatic breast cancer lymph nodes with anti-pan-cytokeratin antibody-coated FF beads to validate the utility of this system in clinical specimens. Under optimal conditions, this ultra-rapid immunostaining method may provide an ancillary method for pathological diagnosis during surgery. (J Histochem Cytochem 58:XXX–XXX, 2010)


  • Open Access

    Application of high-performance magnetic nanobeads to biological sensing devices

    by Yasuaki Kabe, Satoshi Sakamoto, Mamoru Hatakeyama, Yuki Yamaguchi, Makoto Suematsu, Makoto Itonaga, Hiroshi Handa

    Nanomaterials have extensive applications in the life sciences and in clinical diagnosis. We have developed magnetic nanoparticles with high dispersibility and extremely low nonspecific binding to biomolecules and have demonstrated their application in chemical biology (e.g., for the screening of drug receptor proteins). Recently, the excellent properties of nanobeads have made possible the development of novel rapid immunoassay systems and high-precision technologies for exosome detection. For immunoassays, we developed a technology to encapsulate a fluorescent substance in magnetic nanobeads. The fluorescent nanobeads allow the rapid detection of a specific antigen in solution or in tissue specimens. Exosomes, which are released into the blood, are expected to become markers for several diseases, including cancer, but techniques for measuring the absolute quantity of exosomes in biological fluids are lacking. By integrating magnetic nanobead technology with an optical disc system, we developed a novel method for precisely quantifying exosomes in human serum with high sensitivity and high linearity without requiring enrichment procedures. This review focuses on the properties of our magnetic nanobeads, the development of novel biosensors using these nanobeads, and their broad practical applications. Graphical abstract


  • Open Access

    NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation

    by Akihiro Kimura, Masayuki Kitajima, Kyoko Nishida, Satoshi Serada, Minoru Fujimoto, Tetsuji Naka, Yoshiaki Fujii-Kuriyama, Satoshi Sakamato, Takumi Ito, Hiroshi Handa, et al.

    NAD(P)H:quinone oxidoreductase 1 (NQO1) protects cells against oxidative stress and toxic quinones. In this study, we found a novel role of NQO1 in suppressing Toll-like receptor (TLR)–mediated innate immune responses. NQO1-deficient macrophages selectively produced excessive amounts of IL-6, IL-12, and GM-CSF on LPS stimulation, and the deletion of NQO1 in macrophages exacerbated LPS-induced septic shock. NQO1 interacted with the nuclear IκB protein IκB-ζ, which is essential for the TLR-mediated induction of a subset of secondary response genes, including IL-6, and promoted IκB-ζ degradation in a ubiquitin-dependent manner. We demonstrated that PDLIM2, known as the ubiquitin E3 ligase, participates in NQO1-dependent IκB-ζ degradation. NQO1 augmented the association between PDLIM2 and IκB-ζ, resulting in increased IκB-ζ degradation. Collectively, this study describes a mechanism of the NQO1–PDLIM2 complex as a novel and important regulator in the innate immune signaling and suggests the therapeutic potential of NQO1 in TLR-mediated inflammation and disorders.


  • Open Access

    Development of magnet configurations for magnetic immunostaining

    by Miki Kaneko, Shinichi Chikaki, Sachiko Matsuda, Akihiro Kuwahata, Masayuki Namita, Itsuro Saito, Satoshi Sakamoto, Moriaki Kusakabe, Masaki Sekino

    Magnetic immunostaining using a magnet and antibody-labeled fluorescent ferrite (FF) beads is established as a rapid immunostaining. In this study, we proposed the novel configuration of magnets with the large magnetic field gradient and the strong magnetic force for magnetic immunostaining. To confirm the usefulness of the proposed magnet configuration, we performed numerical analysis of the magnetic characteristics of the proposed magnets, and the magnetic immunostaining with FF beads. It was revealed that the proposed magnets generated the strong magnetic force and promoted the immunoreaction rapidly.